PRM trades 42.1% below Wall Street's consensus target of $39.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes PRM achieves its forward estimates and maintains a stable P/E multiple of 17.8x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Perimeter Solutions, Inc. (PRM) has a Wall Street consensus price target of $39.00, based on estimates from 3 covering analysts. With the stock currently trading at $27.45, this represents a potential upside of +42.1%. The company has a market capitalization of $4.48B.
Analyst price targets range from a low of $38.00 to a high of $40.00, representing a 5% spread in expectations. The median target of $39.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, PRM trades at a trailing P/E of -20.0x and forward P/E of 17.8x. Analysts expect EPS to grow +172.2% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IOSPInnospec Inc. | $2.4B | $97.41 | $110.00 | +12.9% | Hold | 19.7x | 9 |
 ASIXAdvanSix Inc. | $437M | $16.22 | $30.80 | +89.9% | Buy | 87.7x | 6 |
 KWRQuaker Houghton | $2.8B | $160.73 | $182.50 | +13.5% | Buy | 20.4x | 16 |
 BCPCBalchem Corp | $5.4B | $166.56 | $215.00 | +29.1% | Buy | 30.8x | 10 |
 ALBAlbemarle Corporation | $12.3B | $104.59 | $194.56 | +86.0% | Buy | 9.1x | 45 |
 AVNTAvient Corporation | $3.8B | $41.17 | $47.75 | +16.0% | Buy | 12.9x | 21 |
 FULH.B. Fuller Company | $2.7B | $50.20 | $64.67 | +28.8% | Buy | 10.3x | 15 |
 CBTCabot Corp. | $4.0B | $76.95 | $94.00 | +22.2% | Buy | 12.1x | 15 |
 TROXTronox Holdings plc | $627M | $3.93 | $7.57 | +92.6% | Buy | — | 17 |
 PRLBProto Labs, Inc. | $2.3B | $98.21 | $87.00 | -11.4% | Hold | 44.4x | 17 |
Quick answers to the most common questions about buying PRM stock.
The consensus Wall Street price target for PRM is $39, representing 42.1% upside from the current price of $27.45. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
PRM has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $39 implies 42.1% upside from current levels.
With a forward P/E of 17.767x, PRM trades at a relatively low valuation. The consensus target of $39 implies 42.1% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $40 for PRM, while the most conservative target is $38. The consensus of $39 represents the median expectation. These targets typically reflect 12-month expectations.
PRM is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PRM stock forecast based on 3 Wall Street analysts shows a consensus price target of $39, with estimates ranging from $38 (bear case) to $40 (bull case). The median consensus rating is "Buy".
PRM trades at a forward P/E ratio of 17.8x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on PRM, with a "Buy" consensus rating and $39 price target (42.1% upside). 3 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PRM analyst price targets range from $38 to $40, a 5% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $39 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.